Cargando…

Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis

BACKGROUND: Individuals with rheumatoid arthritis (RA) are at increased risk for cardiovascular disease, partly due to systemic inflammation and endothelial dysfunction. B‐cells play an important pathogenic role in the inflammatory process that drives RA disease activity. Rituximab, a chimeric murin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsue, Priscilla Y., Scherzer, Rebecca, Grunfeld, Carl, Imboden, John, Wu, Yuaner, del Puerto, Gus, Nitta, Elaine, Shigenaga, Judy, Schnell Heringer, Amanda, Ganz, Peter, Graf, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323827/ https://www.ncbi.nlm.nih.gov/pubmed/25336464 http://dx.doi.org/10.1161/JAHA.114.001267

Ejemplares similares

Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis
por: Graf, Jonathan, et al.
Publicado: (2009)

Effect of HIV‐1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial Dysfunction
por: Thakkar, Anjali B., et al.
Publicado: (2021)

HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Paradox”
por: Kohli, Payal, et al.
Publicado: (2016)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection
por: Parikh, Rushi V., et al.
Publicado: (2016)

Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection
por: Scherzer, Rebecca, et al.
Publicado: (2018)

LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney
por: Feingold, Kenneth R., et al.
Publicado: (2008)

Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients
por: Chen, Ruijun, et al.
Publicado: (2017)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation
por: Hsue, Priscilla Y., et al.
Publicado: (2012)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
por: Sinha, Arjun, et al.
Publicado: (2016)

Rituximab: B cell depletion: case report
Publicado: (2021)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
por: Elshahaly, Mohsen, et al.
Publicado: (2013)

Extraarticular Manifestations of Rheumatoid Arthritis in a Multiethnic Cohort of Predominantly Hispanic and Asian Patients
por: Richman, Nicole C., et al.
Publicado: (2013)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
por: Svenningsson, Anders, et al.
Publicado: (2015)

Rituximab efficiently depletes B cells in lung tumors and normal lung tissue
por: Joly-Battaglini, Albane, et al.
Publicado: (2016)

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis
por: Kobak, Şenol, et al.
Publicado: (2013)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Association between statin use, atherosclerosis, and mortality in HIV-infected adults
por: Phan, Binh An P., et al.
Publicado: (2020)

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
por: van Laar, Jacob M
Publicado: (2010)

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis
por: Lundberg, Sigrid, et al.
Publicado: (2017)

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome
por: Appanna, G D, et al.
Publicado: (2019)

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
por: Mehta, Puja, et al.
Publicado: (2020)

A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
por: Wennmann, Merlin, et al.
Publicado: (2021)

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
por: Cohen, Stanley B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bbaum44mrf7e7dmsk3q5enrgvi